We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.98B
AUM Growth
+$857M
Cap. Flow
+$784M
Cap. Flow %
11.24%
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$132M
2
QCOM icon
Qualcomm
QCOM
+$77.3M
3
ABT icon
Abbott
ABT
+$69.2M
4
BKNG icon
Booking.com
BKNG
+$67.7M
5
KLAC icon
KLA
KLAC
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Technology 29.45%
3 Communication Services 6.73%
4 Industrials 6.43%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFA
426
DELISTED
Informatica
INFA
$1.94M 0.03%
+52,558
New +$1.78M
BGSX
427
DELISTED
Build Acquisition Corp.
BGSX
$1.94M 0.03%
200,000
ACQR
428
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
$1.94M 0.03%
200,000
SBII
429
DELISTED
Sandbridge X2 Corp.
SBII
$1.94M 0.03%
200,000
ACRO
430
DELISTED
Acropolis Infrastructure Acquisition Corp
ACRO
$1.94M 0.03%
+200,000
New +$1.94M
YTPG
431
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$1.93M 0.03%
196,989
-153,011
-44% -$1.51M
RMGC
432
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
$1.9M 0.03%
194,889
AVIR icon
433
Atea Pharmaceuticals
AVIR
$383M
$1.86M 0.03%
208,399
+23,134
+12% +$361K
KLAQ
434
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
$1.84M 0.03%
189,155
KALV
435
DELISTED
KalVista Pharmaceuticals
KALV
$1.84M 0.03%
138,738
+9,387
+7% +$149K
TKNO icon
436
Alpha Teknova
TKNO
$299M
$1.76M 0.03%
85,794
GDRX icon
437
GoodRx Holdings
GDRX
$1.12B
$1.73M 0.02%
52,966
-24,480
-32% -$985K
VPCB
438
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$1.72M 0.02%
175,000
KWEB icon
439
KraneShares CSI China Internet ETF
KWEB
$5.66B
$1.71M 0.02%
+46,737
New +$2.15M
TZPS
440
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$1.7M 0.02%
175,000
QDRO
441
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$1.68M 0.02%
172,066
VERO
442
DELISTED
Venus Concept
VERO
$1.65M 0.02%
5,882
+330
+6% +$95.4K
PRCT icon
443
Procept Biorobotics
PRCT
$1.1B
$1.63M 0.02%
65,000
ACHL
444
DELISTED
Achilles Therapeutics
ACHL
$1.63M 0.02%
+324,387
New +$1.96M
DNUT icon
445
Krispy Kreme
DNUT
$536M
$1.59M 0.02%
84,287
SV
446
DELISTED
Spring Valley Acquisition Corp. Class A Ordinary Share
SV
$1.58M 0.02%
157,810
SRAD icon
447
Sportradar
SRAD
$3.69B
$1.58M 0.02%
89,999
LYEL icon
448
Lyell Immunopharma
LYEL
$328M
$1.56M 0.02%
10,090
-204
-2% -$45.5K
ARYD
449
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$1.55M 0.02%
156,880
-1,599
-1% -$15.9K
RAIN
450
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$1.54M 0.02%
119,700

Similar funds

Woodline Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.

  • Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
  • Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
  • Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
  • Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
  • Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.